CEROCERo Therapeutics Holdings Inc

$0.0125
$0.0015
(13.64%)
Today
Updated: 03:58 PM EDT
Mkt Cap$496,236.00
Vol2.26M

About

CERo Therapeutics Holdings, Inc. is an immunotherapy company, which engages in development of engineered T cell therapeutics for the treatment of cancer. Its platform is designed to redirect patient-derived T cells to eliminate tumors, creating Chimeric Engulfment Receptor T (CER-T) cells used for spanning hematological malignancies and solid tumors. The company was founded on June 8, 2021 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
8

Frequently Asked Questions

What is Market Cap of CERo Therapeutics Holdings Inc.?
What is the 52-week high for CERo Therapeutics Holdings Inc.?
What is the 52-week low for CERo Therapeutics Holdings Inc.?
What is CERo Therapeutics Holdings Inc. stock price today?
What was CERo Therapeutics Holdings Inc. stock price yesterday?
What is the Price-to-Book ratio of CERo Therapeutics Holdings Inc.?
What is the 50-day moving average of CERo Therapeutics Holdings Inc.?
How many employees does CERo Therapeutics Holdings Inc. have?